AstraZeneca and Merck, known as MSD outside of the United States and Canada, today announced that LYNPARZA in combination with abiraterone and prednisone or prednisolone has been approved in Japan for ...
AstraZeneca and Merck MRK, known as MSD outside of the United States and Canada, today announced that LYNPARZA in combination with abiraterone and prednisone or prednisolone (abi/pred) has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback